|
Lechleiter
Takes Lilly’s Helm: What’s In Store?
March
30, 2008--John
Lechleiter is Eli Lilly and Co.’s CEO as of April 1. How will
Lilly’s new leader—a 29-year Lilly veteran—combat the
pending loss of patent protection for the company’s best-selling
drug and a slumping stock price, among other challenges?
Lechleiter thinks communication is a crucial part of his new job,
and believes that leaders need to be visible. His top priority
will be to push forward on the company's pipeline of new drugs,
and Lechleiter says he sees biotech products as a key for the
company. Read this profile of Lechleiter: AP/BusinessWeek
|
